Page 13 - covid-19-pandemic-malaysia-journey

and monitoring of daily stock balance status at MOH facilities beginning April 2020. These

data were presented during the CPC PSP and MOH CPRC meetings every week.

The PSP also facilitated the WHO Solidarity Trial via fast-track approvals of investigational

products (IPs) to be used in these clinical trials, including Remdesivir. All IPs were
successfully evaluated within four working days without jeopardizing the quality and

adherence to the international regulatory requirements. Assurance of quality and safety of

all foreign and local products whether for procurement or donations were also verified
through the registration status of drugs and cosmetics notification.

Discussion during the CPC
Meeting

7